arrow_back Back Filing freshness 10-Q Q3 FY2026 SEC EDGAR

Elevance Health, Inc.

ELV
$432.05 ▼ -2.36 (-0.54%) at close
Healthcare ·Hospital & Medical Service Plans ·USHospital & Medical Service Plans
76 Visible periods
34 Metrics
Peer-ranked Benchmarks
Price Chart
50
Health
Fair
Bullish
auto_awesome

Analytical Summary

Elevance Health, Inc. shows strong fundamentals with top-quartile Return on Common Equity (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $93.6B
Dividend Yield 0.40%
Revenue Growth 1.4% →
Op. Margin 2.5% ↘
ROIC 1.3% ↘
FCF / Share $4.62 ↘
Trailing P/E 68.6x
Price / Book 2.1x
FCF Yield 1.1%
Debt / Equity 0.69
info Valuation on last close. End-of-day price, Nov 5, 2026.

76-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$51.43B
↑ +1.4% —
Net Income Profit after all expenses
$1.36B
↑ +14.8% —
Operating Margin Operating profit as % of sales
2.5%
↓ -29.4% 39th
FCF / Share Free cash flow per share
$4.62
↓ -38.4% —
Long-Term Debt Long-term obligations
$30.76B
↓ -0.9% —
trending_up

Bullish Indicators

  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Profitability ↓
37
Returns ↓
76
Financial Health ↑
38
Cash Quality ↓
42

Dividend History

Dividend / share · sourced from SEC filings
$5.92 Latest / share
+15.6% YoY
+14.5% 10-yr CAGR

bar_chart Data from SEC EDGAR XBRL filings

Synced 5 days ago 20 years · 76 quarters